Skip to main content
logo
Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.455
+0.075 (5.43%)
Aug 21, 2026, 11:28 AM EDT - Market open

Dermata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6632514
Market Cap Growth
52.38%124.01%27.62%-56.38%-65.85%-
Enterprise Value
12-3-4-32
Last Close Price
1.382.3213.5091.50981.604176.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.590.991.770.340.821.43
P/TBV Ratio
1.620.991.770.340.821.43

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.26-1.21-2.02-1.17-1.04-1.07
Net Debt / EBITDA Ratio
-----1.37
Quick Ratio
2.414.591.604.586.787.12
Current Ratio
2.814.791.794.917.537.66
Return on Equity (ROE)
-183.89%-194.20%-310.44%-125.96%-119.18%-228.09%
Return on Assets (ROA)
-89.88%-85.25%-135.86%-67.36%-65.13%-80.31%
Return on Capital Employed (ROCE)
-246.60%-124.90%-801.60%-126.50%-160.70%-77.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-150.77%-122.48%-446.00%-361.07%-194.19%-54.53%
Buyback Yield / Dilution
-391.13%-505.46%-684.76%---
SEC Filings: 10-K · 10-Q